Skip to Main Content

2,563

Views

8

CrossRef citations to date

0

Altmetric

Research Article

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey

J. P. Sevillaa Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USACorrespondence[email protected]

https://orcid.org/0000-0001-9807-657X View further author information

,

Andrew Stawasza Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USA

https://orcid.org/0000-0002-9902-1252 View further author information

,

Daria Burnesa Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAView further author information

,

Anubhav Agarwala Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAView further author information

,

Basak Hacibedelb Health Economics and Outcomes Research, Pfizer Turkey, Istanbul, TurkeyView further author information

,

Kerem Helvacioglub Health Economics and Outcomes Research, Pfizer Turkey, Istanbul, TurkeyView further author information

,

Reiko Satoc Health Economics and Outcomes Research, Pfizer Inc, Collegeville, PA, USAView further author information

&

David E. Blooma Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAView further author information